$2.58
0.093.61%
al cierre: -
$2.58
0.000.00%
After hour: 4:19 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Inovio Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 10
Estimación de BPA
$-0.490
Estimación de ingresos trimestrales
$8.33K
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$182.34K
Analice el historial de beneficios de Inovio Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
INO | Inovio Pharmaceuticals | -$0.89 | -$0.49 | — | — | $0.00 | $8.33K | — | — | 11/10/2025 | |
INO | Inovio Pharmaceuticals | -$1.19 | -$0.62 | -$0.61 | 1.61% | $100.76K | $25.00K | $0.00 | -100.00% | 08/12/2025 | |
INO | Inovio Pharmaceuticals | -$1.31 | -$0.74 | -$0.51 | 31.08% | $0.00 | $10.00K | $65.34K | 553.43% | 05/13/2025 | |
INO | Inovio Pharmaceuticals | -$1.10 | -$0.83 | -$0.65 | 21.69% | $103.00K | $25.00K | $117.00K | 368.00% | 03/18/2025 | |
INO | Inovio Pharmaceuticals | -$1.56 | -$1.13 | -$0.89 | 21.24% | $388.45K | $104.50K | $0.00 | -100.00% | 11/14/2024 | |
INO | Inovio Pharmaceuticals | -$1.61 | -$1.10 | -$1.19 | -8.18% | $225.97K | $120.00K | $100.76K | -16.03% | 08/08/2024 | |
INO | Inovio Pharmaceuticals | -$1.89 | -$1.00 | -$1.31 | -31.00% | $114.94K | — | $0.00 | — | 05/13/2024 | |
INO | Inovio Pharmaceuticals | -$2.64 | -$1.27 | -$1.10 | 13.39% | $125.00K | $340.00K | $103.00K | -69.71% | 03/06/2024 | |
INO | Inovio Pharmaceuticals | -$1.80 | -$1.56 | -$1.56 | 0.00% | $9.15M | $120.00K | $388.45K | 223.71% | 11/09/2023 | |
INO | Inovio Pharmaceuticals | -$5.52 | -$1.68 | -$1.56 | 7.14% | $784.39K | $260.00K | $225.97K | -13.09% | 08/09/2023 | |
INO | Inovio Pharmaceuticals | -$4.32 | -$1.68 | -$1.92 | -14.29% | $199.07K | $270.00K | $114.94K | -57.43% | 05/10/2023 | |
INO | Inovio Pharmaceuticals | -$6.00 | -$2.04 | -$2.64 | -29.41% | $839.00K | $340.00K | $125.00K | -63.24% | 03/01/2023 | |
INO | Inovio Pharmaceuticals | -$3.48 | -$3.60 | -$1.80 | 50.00% | $291.70K | $620.00K | $9.15M | 1376.45% | 11/08/2022 | |
INO | Inovio Pharmaceuticals | -$4.68 | -$3.72 | -$5.52 | -48.39% | $272.82K | $520.00K | $784.39K | 50.85% | 08/09/2022 | |
INO | Inovio Pharmaceuticals | -$3.24 | -$4.08 | -$4.32 | -5.88% | $371.12K | $670.00K | $199.07K | -70.29% | 05/10/2022 | |
INO | Inovio Pharmaceuticals | -$1.68 | -$3.84 | -$6.00 | -56.25% | $5.58M | $2.84M | $839.00K | -70.46% | 03/01/2022 | |
INO | Inovio Pharmaceuticals | -$3.12 | -$3.96 | -$3.48 | 12.12% | $236.18M | $970.00K | $291.70K | -69.93% | 11/09/2021 | |
INO | Inovio Pharmaceuticals | -$2.40 | -$3.00 | -$4.68 | -56.00% | $267.19K | $1.21M | $272.82K | -77.45% | 08/09/2021 | |
INO | Inovio Pharmaceuticals | -$3.12 | -$2.16 | -$3.24 | -50.00% | $1.33M | $850.00K | $371.12K | -56.34% | 05/10/2021 | |
INO | Inovio Pharmaceuticals | -$4.56 | -$2.64 | -$1.68 | 36.36% | $279.00K | $1.11M | $5.58M | 402.79% | 03/01/2021 | |
INO | Inovio Pharmaceuticals | -$3.00 | -$2.28 | -$3.12 | -36.84% | $866.86K | $3.05M | $236.18M | 7643.54% | 11/09/2020 |
Inovio Pharmaceuticals (INO) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.61 | $-0.62 | 1.61 % |
| Q1 | 2025-05-13 | $-0.51 | $-0.74 | 31.1 % |
| Q4 | 2025-03-18 | $-0.65 | $-0.83 | 21.7 % |
| Q3 | 2024-11-14 | $-0.89 | $-1.13 | 21.2 % |
Inovio Pharmaceuticals (INO) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $0 | $25.00K | -100.0 % |
| Q1 | 2025-05-13 | $65.34K | $10.00K | 553.4 % |
| Q4 | 2025-03-18 | $117.00K | $25.00K | 368.0 % |
| Q3 | 2024-11-14 | $0 | $104.50K | -100.0 % |
PREGUNTAS FRECUENTES
¿Cuándo Inovio Pharmaceuticals (NASDAQ:INO) publicará los resultados?
Está previsto que Inovio Pharmaceuticals (INO) presente resultados el noviembre 10, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Inovio Pharmaceuticals (NASDAQ:INO)?
El BPA real fue de $-0.61, que superó la estimación de $-0.62.
¿Cuáles fueron los ingresos de Inovio Pharmaceuticals (NASDAQ:INO)?
Los ingresos reales fueron $0K, que no alcanzó la estimación de $25K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.